Sign up to save your podcasts
Or
Share Advancing AML treatment: evidence-based regimens and guidelines for R/R AML management | S6E2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Advancing AML treatment: evidence-based regimens and guidelines for R/R AML management | S6E2
The AML expert series: Innovations in molecular testing, emerging therapies & targeted treatments
In this episode Prof. Amer Zeidan, MBBS, MHS, and Dr. Eunice Wang, MD, discuss:
The latest evidence-based regimens and guidelines for targeted treatment in IDH-mutant relapsed/refractory acute myeloid leukemia (R/R AML)
Routine clinical practice application, and real-world outcomes
To access the video-based podcast episode, and learn more about the full series on molecular testing and targeted treatments for improved patient outcomes in R/R AML, visit https://springermedicine.com/aml-expert-series-overview/50892434
Intended for healthcare professionals only.
Supported by an independent educational grant from Rigel.
© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.
View all episodes
By Springer Health+ IMEThe AML expert series: Innovations in molecular testing, emerging therapies & targeted treatments
In this episode Prof. Amer Zeidan, MBBS, MHS, and Dr. Eunice Wang, MD, discuss:
The latest evidence-based regimens and guidelines for targeted treatment in IDH-mutant relapsed/refractory acute myeloid leukemia (R/R AML)
Routine clinical practice application, and real-world outcomes
To access the video-based podcast episode, and learn more about the full series on molecular testing and targeted treatments for improved patient outcomes in R/R AML, visit https://springermedicine.com/aml-expert-series-overview/50892434
Intended for healthcare professionals only.
Supported by an independent educational grant from Rigel.
© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.